Medicinova (MNOV) Asset Utilization Ratio (2012 - 2026)

Medicinova (MNOV) posted quarterly Asset Utilization Ratio of 0.01 for Q4 2025, down 65.96% quarter-over-quarter from 0.03 in Q3 2025.

Medicinova (MNOV) Asset Utilization Ratio (2012 - 2026) Analysis & Trends

Medicinova (MNOV) has reported Asset Utilization Ratio for 7 consecutive years, with 0.01 the latest figure, recorded in Q4 2025.

In Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.01; the TTM figure through Dec 2025 stood at 0.01 (changed N/A YoY), while the FY2025 annual figure was 0.01, changed N/A from the prior year.
Asset Utilization Ratio slipped to 0.01 in Q4 2025 per MNOV's latest filing, from 0.03 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.12 in Q1 2021 and bottomed at 0.01 in Q4 2025.
Historically, Asset Utilization Ratio has averaged 0.04 across 3 years, with a median of 0.03 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.71 Bn	130.86 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.60 Bn	77.60 Bn	3.93 Bn	0.38
3	Argenx Se	64.82 Bn	59.63 Bn	1.37 Bn	-
4	Moderna	57.92 Bn	52.79 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.88 Bn	36.78 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.46 Bn	28.15 Bn	992.69 Mn	0.90
7	BioNTech SE	27.96 Bn	9.57 Bn	668.28 Mn	0.13
8	Insmed	27.35 Bn	26.19 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	Medicinova	68.42 Mn	68.42 Mn	317,759.00	0.02

Download Data